Stephen Parker

Part of Houlihan Lokey, Inc., GCA Altium Ltd. is a brokerage services provider. The private company is based in London, UK. The British company was founded by Michael James Hough. Philip Adams has been the CEO of the company since 1996. GCA Altium was acquired by GCA Corp. (Japan), part of Houlihan Lokey, Inc. from September 27, 2021 on July 31, 2016 for $110.25 million.

Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK.

The Barings group collapsed in February 1995 as a direct result of unauthorised trading conducted on the Singapore International Monetary Exchange by Nick Leeson, the general manager of Barings Futures (Singapore) Ltd (BFS). The frauds were perpetrated through an account numbered 88888 and resulted in losses amounting to £791 million. The Barings group had funded these losses, in ignorance of the real use to which the funds were being put. It was BFS' inability to repay its debts to the other group companies that brought down the group.

Celtic Pharma Management LP is a private equity firm founded by Stephen Evans Freke and John Mayo in 2004. The firm headquartered in Bermuda.

Celtic Pharma Development UK Plc provides financial management services. The company was founded in 2005 and is located in London, GB

Novacta Biosystems Ltd. discovered and developed drugs for treatment of bacterial infections. Its products included lantibiotic/bacteriocin variants, as well as a development candidate for the treatment of C. difficile infection. The company was founded by John Michael Dawson on February 14, 2015 and was headquartered in London, the United Kingdom.

Beehive Capital LLP (Beehive Capital) is a private equity firm founded in 2002. The firm is headquartered in London, United Kingdom.

PBB Devices Ltd. is engaged in the commercialization of scientific research into optoelectronics and the provision of legal manufacturer services. The firm offers products for various applications, such as general practitioner and physician offices and routine assessment of diabetic complications. The company was founded by Jody Brown, Vincent Peter Crabtree and Peter Smith on September 25, 2002 and is headquartered in Reading, the United Kingdom.

Sareum Ltd. provides drug discovery services for treatment of cancer. The company develops robust pipeline of novel small molecule cancer drug candidates for partnering with pharmaceutical companies. Sareum is headquartered in Cambridge, UK

Ah Animal Healthcare Ltd. develops biosuperior protein therapeutics. The company’s services include biopharmaceutical discovery, process development and GMP manufacturing. It focuses on particular characteristics of biologic drugs that include product presentation and stability, pharmacokinetics, pharmacodynamics, immunogenicity and drug delivery. The company was founded in 1989 and is headquartered in Reading, the United Kingdom.

Bedford Royalties Ltd. used to provide pharmaceutical services. The company was founded on August 26, 2011 and was headquartered in Reading, the United Kingdom.

Liverpool Chirochem Ltd. Produces and supply small organic molecules for biotech and pharmaceutical research and development. The firm offers building blocks, screening libraries and chemistry services. The company was founded by Jianjun Wu and Paul Colbon is headquartered in Liverpool, the United Kingdom.

Gammadelta Therapeutics Ltd. is developing the potential of gamma delta (?d) cells to create improved immunotherapy of cancer and other serious diseases. The company was founded by Raj Mehta in 2016 and is headquartered in London, the United Kingdom.

Drishti Discoveries Ltd. is a British company founded in 2019 that aims to develop a gene therapy that provides a long-term knockdown of target gene expression. Drishti Discoveries is based in Cambridge, UK. The company uses technology to achieve this goal. The company's website uses cookies to improve user experience while navigating through the website. The website also uses third-party cookies to analyze and understand how users interact with the website. Necessary cookies are used to ensure basic functionalities and security features of the website. Functional cookies are used to perform certain functionalities like sharing the content of the website on social media platforms, collect feedback, and other third-party features.